Hematologic Malignancies
Browse through articles and resources designed to support advanced practitioners to diagnose, treat, and manage cancers of the blood, including leukemia, lymphoma, and multiple myeloma.
Safety in Subsequent Lines of Therapy in Patients With Relapsed Refractory Follicular Lymphoma
By Tajuana Bradley, MS, FNP-BC, Mark Davis, MPAS, PA-C, Julie Martin, DNP, AOCN, NP, Susan Woodward, MSN, APRN, AOCNP
November 5, 2024
Seamless Navigation of Bispecific Therapies: Optimizing Management and Outpatient Access With a Focus on Coordination
By Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, Amir Ali, PharmD, BCOP, James Davis, PharmD, BCOP, Tyler Sandahl, PharmD, BCOP, Victoria Nachar, PharmD, BCOP, Robert Mancini, PharmD, BCOP, FHOPA
September 11, 2024
Advances in Myelofibrosis Management: New Janus Kinase Inhibitors Beyond Ruxolitinib
By Justin Arnall, PharmD, BCOP, Lindsey Lyle, MS, PA-C, Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP
May 22, 2024
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
Presented by Beth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD
April 17, 2024
A Comprehensive Bone Marrow Aspirate and Biopsy Educational Program Utilizing Task Trainers
Jessica Casselberry, DNP, ANP-BC, AOCNP®, and Jennifer Fisher, DNP, WHNP
March 25, 2024
Peripheral T-Cell Lymphoma, Not Otherwise Specified: Diagnosis and Therapeutic Approaches for the Advanced Practice Provider
By Karla V. Ow, MSN, APRN, AOCNP, Ann Vo, MSN, APRN, FNP, Jonathan Cunningham, MPAS, PA-C
February 14, 2024
Role of Preemptive Cytomegalovirus Hyperimmunoglobulin in Cytomegalovirus Viremia Following Stem Cell Transplant: An Integrative Review
Jaci Whittaker, MSN, APRN, FNP-BC, Ashley Martinez, DNP, APRN, FNP-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FANP, FAANP, FAAN
November 29, 2023
Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner
Ekaterina Kachur, PharmD, BCOP, Jai N. Patel, PharmD, BCOP, CPP, Allison L. Morse, PharmD, BCOP, Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, and Justin R. Arnall, PharmD, BCOP
September 19, 2023
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma
Rakesh Popat,(1) BSc, MBBS, MRCP, FRCPath, PhD, Sagar Lonial,(2) MD, FACP, Peter M. Voorhees,(3) MD, Simona Degli Esposti,(4) MD, Boris Gorsh,(5a) PharmD, Ira Gupta,(5a) MD, Joanna Opalinska,(5) PhD, Sandhya Sapra,(5) PhD, Trisha Piontek,(5) BS, RN, Zangdong He,(5) PhD, David Kleinman,(6) MD, MBA, Debra Schaumberg,(7) SCD, OD, MPH, Antoine Regnault,(8) PhD, Juliette Meunier,(8) MSc, and Laurie Eliason,(5a) MPH
September 19, 2023
Knowing Your Target: Altered Mental Status From an Unsuspected Source
Sarah Hemstetter, MSN, CRNP, AOCNP®
September 19, 2023
Anti-Spike Antibody Responses in Allogeneic Stem Cell Transplant Recipients to Two Doses of COVID-19 mRNA Vaccination: A Retrospective, Single-Center Analysis
Jaime L. Shahan, MPAS, PA-C, Robert H. Collins, MD, Prapti Patel, MD, Yazan F. Madanat, MD, and Madhuri Vusirikala, MD
July 17, 2023
Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin
Rebecca Lu, MSN, FNP-C, Ashley Morphey, RN, MSN, CCRP, Felicia Diaz, MSN, APRN, FNP-BC, AOCNP®, Jessica Chen, RN, MSN, OCN®, FNP-C, Azadeh Razmandi, OD, FAAO, and Tiffany Richards, PhD, ANP-BC, AOCNP®
May 23, 2023
Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia
Sara M. Tinsley-Vance, PhD, APRN, AOCN®
May 22, 2023
Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
Presented by Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO, Sandra E. Kurtin,(2) PhD, ANP-C, AOCN®, FAPO, and Rasheda Persinger,(3) MSN, AGNP-C, AOCNP®
April 26, 2023
Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma
Presented by Cesar Rodriguez, MD, and Donna Catamero, ANP-BC, OCN®, CCRC
April 26, 2023
Physical Activity in Multiple Myeloma: A Review of the Current Literature
Michaela Hillengass,(1) RN, ACSM-CPT, Janine Joseph,(1) MS, MBA, Jane McCarthy, and Jens Hillengass,(1) MD, PhD
March 22, 2023
Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Gwen Hua,(1) PharmD, BCOP, Ryan Scanlan,(2) PharmD Candidate, Rachael Straining,(1) PharmD, BCOP, and Daniel S. Carlson,(3) DO
March 22, 2023
Convergence of Hematology and Rheumatology: A Case Study
Mariangel Prieto, MSN, APRN, FNP-BC, AOCNP®
March 22, 2023
The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials
Ly Dsouza, PA-C, MPAS
January 18, 2023
Role of Luspatercept in the Management of Lower-Risk Myelodysplastic Syndromes
Sara M. Tinsley-Vance,(1) PhD, APRN, AOCN®, Mark Davis,(2) MPAS, PA-C, and Olalekan Ajayi,(3) PharmD, MBA
January 18, 2023
Polatuzumab Vedotin for the Front-Line Treatment of Diffuse Large B-Cell Lymphoma: A New Standard of Care?
James A. Davis, PharmD, BCOP, Abigail Shockley, PharmD, Amanda Herbst, PA-C, and Lindsey Hendrickson, DNP, APRN, FNP-C
January 18, 2023
What Is Happening to This Patient With a Rare Leukemia?
Amandine Ndje, MS, MBA, APRN, FNP-C, and Jacqueline B. Broadway-Duren, PhD, DNP, APRN, FNP-BC
November 22, 2022
Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type
Neda Alrawashdh,(1,2) PhD, PharmD, Ali McBride,(3) PharmD, MS, BCPS, Mok Oh,(1) PhD, PharmD, Nimer Alkhatib,(1) PhD, PharmD, Christopher Lee,(4) PhD, RN, FAHA, FAAN, FHFSA, Jennifer Martin,(5) MA, Karen MacDonald,(6) PhD, RN, and Ivo Abraham,(1,3,6) PhD, RN
November 21, 2022
Development of a Standardized Bone Marrow Procedure Training and Competency Toolkit for Advanced Practice Providers in a Large Community Oncology Practice
Katharine Lord,(1) PA-C, Sara Toth,(2) APRN, FNP-C, AOCNP®, AGN-BC, Jennifer Potter,(3) PA-C, Katherine Sellers,(4) PA-C, Monica White,(5) APRN, CNS-AH, ACNP-BC, AOCNP®, Anne Neugent,(4) APRN, FNP-C, and Tracy Martin,(4) APRN, ANP-C, AOCNP®, BMTCN, NursEd
September 20, 2022
Hematologic Malignancies: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
P. Andrew Allred, MS, PA-C, Amy Pierre, MSN, ANP-BC, Meredith Beaton, MSN, RN, Pamela Lee, NP, MSN, and Amber Koehler, PA-C
August 24, 2022
Richter Transformation: Clinical Manifestations, Evaluation, and Management
Melanie Douglas, MS, PA-C
July 20, 2022
An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia
Jackie Broadway-Duren, PhD, DNP, APRN, FNP-BC
July 20, 2022
Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Matthew Waggoner,(1) MS, John Katsetos,(1) PA-C, Emilee Thomas,(1) MBA, MPH, PA-C, Ilene Galinsky,(2) BSN, MSN, ANP-C, and Heather Fox,(3) PA-C
May 18, 2022
Molecular Testing in Hematologic Malignancies
Laura J. Zitella, MS, RN, ACNP-BC, AOCN®
April 21, 2022
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
Ashley Leak Bryant,(1) PhD, RN, OCN®, FAAN, and Kaitlyn Buhlinger,(2) PharmD, BCOP, CPP
April 21, 2022
New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma
Alli McClanahan, APRN, and Megan Spychalla, PA-C
April 21, 2022
Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
Ashley Ames, FNP-BC, and Diane Lee, AGPCNP-BC
April 21, 2022
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy
Lisa Nodzon, PhD, APRN, AOCNP®, Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, and Sara Tinsley, PhD, APRN, AOCN®
March 19, 2022
Lower Extremity Edema: More Than Just the Routine Workup
Alexis Brimm Akins, MSN, CRNP, FNP-C
March 19, 2022
Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
Jessica Thomas, MSN, APRN, FNP-C, AOCNP®, Christi Bowe, MSN, APRN, ANP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
January 19, 2022
Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Emily Behren Ketchum, PharmD, Andrea Clarke, PharmD, BCOP, and Amber B. Clemmons, PharmD, BCOP
January 19, 2022
Mysterious Arm Swelling in a Patient With Non-Hodgkin Lymphoma Complicated by Superior Vena Cava Syndrome
Jessica S. Jang, RN, MSN, ACNP-BC, and Jeffrey S. Jang, BS
January 18, 2022
Development and Implementation of an Advanced Practitioner–Led Survivorship Clinic for Patients Status Post Allogeneic Transplant
Linda K. Baer,(1) MSN, APRN, AOCNP®, Lauren Brister,(1) MSN, APRN, AOCNP®, and Susan R. Mazanec,(1,2) PhD, RN, AOCN®, FAAN
November 24, 2021
Telehealth Interventions for Supportive Management and Early Recognition of Treatment-Related Symptoms in Patients With Hematologic Malignancies
Chasity Yajima, MSN, APRN, FNP-C, AOCNP®, Christi Bowe, DNP, APRN, ANP-C, NPD-BC, CPHQ, Diane Barber, PhD, APRN, ANP-BC, AOCNP®, FAANP, FAAN, and Joyce Dains, DrPH, JD, APRN, FNP-BC, FAANP, FAAN
November 24, 2021
Early Detection of Vulvovaginal Graft-Versus-Host Disease: An Integrative Review
Payton L. Ten Hagen, DNP, APRN, FNP-C, Christi Bowe, MSN, APRN, ANP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
September 22, 2021
Short- and Long-Term Outcomes of Hematologic Malignancy Patients After Cardiopulmonary Resuscitation: Experience of a Large Oncology Center
Mary Lou Warren, DNP, APRN, CNS-CC, FCCM, Virginia V. Schneider, MPAS, PA-C, Yun Qing, MHS, PhD, Lei Feng, MS, Jeanne Y. Campbell, MPAS, PA-C, Jason W. Myers, ACNP-BC, Marian Von-Maszewski, MD, and Cristina Gutierrez, MD
September 21, 2021
Hematologic Malignancies: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Amber B. Koehler, PA-C, MS, P. Andrew Allred, MS, PA-C, and Donna Catamero, ANP-BC, OCN®, CCRC
August 25, 2021
Management of Adverse Events Associated With Tyrosine Kinase Inhibitor Use in Adult Patients With Chronic Myeloid Leukemia in Chronic Phase: An Advanced Practice Perspective
Stephanie Bauer, RN, MSN, BC-FNP, Holly Comer, MSN, APRN, Brooke Ramsey, RN, MSN, ANP-BC, and Katy Thomas, RN, MSN, ANP-C
July 12, 2021
A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, and Daniel Thompson,(2) PharmD
May 19, 2021
Essential Thrombocythemia in a 15-Year-Old Female: Presentation, Workup, and Treatment Considerations in the Pediatric Population
Crystal Flagg, MPAS, PA-C, and Brad Pierce, MPAS, PA-C
May 19, 2021
Optimizing Treatment of Chronic Lymphocytic Leukemia
Presented by Sandra E. Kurtin, PhD, ANP-C, AOCN®
April 21, 2021
Improving Outcomes in Hematopoietic Stem Cell Transplant: Recent Advances
Presented by Maritza Alencar, DNP, MBA, APRN-BC, BMTCN
April 21, 2021
Diagnosis and Treatment of AL and ATTR Amyloidosis
Presented by Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®
April 21, 2021
A Pharmacist-Led Oral Chemotherapy Program’s Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
Taylor Dennison,(1,2) PharmD, Allison M. Deal,(3) MS, Matthew Foster,(1,3) MD, John Valgus,(1,2) PharmD, MHA, BCOP, and Benyam Muluneh,(2) PharmD, BCOP, CPP
March 17, 2021
Development, Implementation, and Patient Perspectives of the Women’s Integrative Sexual Health Program: A Program Designed to Address the Sexual Side Effects of Cancer Treatment
Lori A. Seaborne, MPAS, PA-C, Megan Peterson, DNP, David M. Kushner, MD, Janelle Sobecki, MD, MA, and Joanne K. Rash, MPAS, PA-C
January 19, 2021
Advanced Practice Perspectives on Preventing and Managing Tumor Lysis Syndrome and Neutropenia in Chronic Lymphocytic Leukemia
Amy Goodrich, RN, MSN, CRNP
January 19, 2021
Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
Lauren M. Garner, PharmD, BCPPS, Theresa Kline, PharmD, BCPS, BCCP, Jordan Miller, PharmD, BCOP, CPP, Allison Deal, MS, Anqi Zhu, MS, PhD(c), Margaret R. Sketch, PharmD, MPH, Catherine C. Coombs, MD, and Benyam Muluneh, PharmD, BCOP, CPP
January 18, 2021
Acute Myeloid Leukemia: Advanced Practice Management From Presentation to Cure
Meredith Beaton, RN, MSN, AG-ACNP, Glen J. Peterson, RN, DNP, ACNP, and Kelly O’Brien, RN, MSN, ANP-C, ACNP-BC
November 17, 2020
Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation
Halina Rubin,(1) RPh, Jayesh Mehta,(1,2) MD, Jessica L. Fong,(1) PharmD, Deborah Greenberg,(1) PharmD, Solomiya Gruschak,(1,2) BS, and Steven Trifilio,(1,2) RPh
September 23, 2020
Hematologic Malignancies: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Amy Pierre,(1) MSN, ANP-BC, P. Andrew Allred,(2) MS, PA-C, and Allyson Price,(3) PA-C
August 26, 2020
Patient-Reported Outcomes and Assessment of Quality of Life: A Focus on Multiple Myeloma
MaryAnn Fragola, ANP-C, DNP
July 22, 2020
Polatuzumab Vedotin for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Transplant-Ineligible Patients
Melanie Douglas, MS, PA-C
July 22, 2020
Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management
Miriam Hobbs, DNP, APRN, CNP, Amie Fonder, PA-C, and Yi L. Hwa, DNP, APRN, CNP
May 27, 2020
Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia
Ashley Leak Bryant,(1) PhD, RN-BC, OCN®, Ya-Ning Chan,(1) MSN, RN, Jaime Richardson,(1) BSN, RN, OCN®, CCRP, Matthew Foster,(1) MD, Susie Owenby,(2) BSN, RN, and Debra Wujcik,(2) PhD, RN
May 26, 2020
Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
Presented by Edward Libby,(1) MD, and Josh Epworth,(2) ARNP
April 21, 2020
Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma
Presented by Amy E. Pierre,(1) MSN, ANP-BC, and Joshua Richter,(2) MD
April 21, 2020
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
Presented by Mazyar Shadman,(1,2) MD, MPH, and Amy Goodrich,(3) CRNP
April 20, 2020
Addressing the Challenges of Aggressive Lymphomas
Presented by Katherine L. Byar, MSN, ANP-BC, BMTCN®, and Matthew Lunning, DO, FACP
April 20, 2020
Glasdegib: A Novel Hedgehog Pathway Inhibitor for Acute Myeloid Leukemia
Daniel L. Thompson,(1) PharmD Candidate, and Donald C. Moore,(2) PharmD, BCPS, BCOP, DPLA
March 13, 2020
Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid Leukemia
Dennis Marjoncu,(1) PharmD, BCOP, and Benjamin Andrick,(2) PharmD, BCOP
January 20, 2020
Chronic Neutrophilic Leukemia: A Case Report of a Rare Myeloproliferative Neoplasm With a CSF3R Mutation
Lorinda A. Coombs, PhD, FNP-BC, AOCNP
November 20, 2019
AL Amyloidosis: Unfolding a Complex Disease
Rebecca Lu, MS, FNP, and Tiffany A. Richards, PhD, ANP-BC
November 20, 2019
The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Cytokine Release Syndrome From CAR T-Cell Therapy
Sherry Adkins, MSN, ANP-C
November 20, 2019
Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Amber C. King, PharmD, BCOP, and Jennifer S. Orozco, PharmD
November 20, 2019
Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma
Sutton Watson,(1) PharmD, and Justin Bradley Marx,(2) PharmD, BCPS
November 20, 2019
Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation
Steven Trifilio, RPh, and Jayesh Mehta, MD
September 18, 2019
A Review of PI3K Inhibitors in B-Cell Malignancies
Laura Cannon,(1) PharmD, MPH, Emmeline C. Academia,(2) PharmD, and Ashley E. Glode,(2) PharmD, BCOP
September 18, 2019
Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
Kori Daniels, PharmD, and Amber Clemmons, PharmD, BCOP
September 18, 2019
2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Hematologic Malignancies
Amy Pierre, MSN, ANP-BC, and Nancy M. Nix, PharmD, BCPS, BCOP
August 22, 2019
Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia
Shelby L. Merchant, PharmD, Kathryn Culos, PharmD, BCOP, and Houston Wyatt, PharmD, CSP
July 22, 2019
Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
Yi L. Hwa, DNP,(1) Teresa Fogaren, MSN, AGNP-C,(2) Allison Sams, AGPCNP-BC,(3) Douglas V. Faller, MD, PhD,(4) Dawn M. Stull, PharmD, BCOP,(5) Sara Thuenemann, RN, MSN, DHSc,(6) and Lisa Mendelson, MSN, AGPCNP-BC(7)
July 22, 2019
Advances in the Management of Myeloma
Presented by Beth Faiman, PhD, MSN, APRN-BC, AOCN®, and Rachid Baz, MD
April 22, 2019
Sequencing Therapies in Indolent Lymphomas
Presented by Philip A. Thompson, MB, BS, and Lisa Nodzon, PhD, ARNP, AOCNP®
April 22, 2019
Modern Management of Classical Hodgkin Lymphoma
Presented by Amy Goodrich, CRNP, and Jose D. Sandoval-Sus, MD
April 22, 2019
New Directions in Acute Myeloid Leukemia
Presented by Kelda Gardner, PA-C, MHS, and Melinda Tran, PharmD, BCOP
April 19, 2019
Differential Diagnosis and Testing for Hematologic Malignancies
Presented by Sandra E. Kurtin, PhD, ANP-C, AOCN®, and Jennifer Knight, MD
April 19, 2019
Impact of a Replacement Algorithm for Vitamin D Deficiency in Adult Hematopoietic Stem Cell Transplant Patients
Sheila A. Kenny,(1) MSN, RN, ANP-BC, Karen Collum,(1) DNP, RN, OCN®, Catherine A. Featherstone,(1) MSN, RN, FNP-BC, Azeez Farooki,(1,2) MD, and Ann Jakubowski,(1,2) PhD, MD
March 24, 2019
Gemtuzumab Ozogamicin: Back Again
Chris Selby,(1) PharmD, BCOP, Lisa R. Yacko,(2) PharmD, BCPS, and Ashley E. Glode,(3) PharmD, BCOP
January 21, 2019
Breast Implant–Associated Anaplastic Large Cell Lymphoma: What We Know
Nadia E. K. DePaola, MS, PA-C, and Heather Coggins, MS, PA-C
January 21, 2019
Diagnostic Snapshot: Painful Nodules and Recurrent Fever in a Patient With Acute Lymphoblastic Leukemia
Alexis C. Geppner, MLS(ASCP), PA-C
November 27, 2018
Interdisciplinary Educational Checklist for Allogeneic Stem Cell Transplant Patients
Jean A. Ridgeway, DNP, APN, NP-C, AOCN®
September 14, 2018
Inotuzumab Ozogamicin in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Sherry Williams, PharmD, BCOP, and Miryoung Kim, PharmD, BCOP
September 14, 2018
Diagnostic Snapshot: Acute Edema in the Oncology Patient
Alexandra Trudeau, BSN, BS, RN, CNOR, Danielle Bean, BSN, RN, Donna Fleming, MSN, RN, FNP-C, Glaiza Boado, BSN, RN, Natalia Samuels, MSN, RN, and Reshmi Kurup, BS, RN
September 14, 2018
Subcutaneous Rituximab in Follicular Lymphoma, Chronic Lymphocytic Leukemia, and Diffuse Large B-Cell Lymphoma
Bradley J. Yelvington, PharmD
July 24, 2018
Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia
Craig W. Freyer, PharmD, BCOP
July 24, 2018
Current Issue
Immediate Patient Access to Test Results and the Impact on Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
November 26, 2024
Obinutuzumab Infusion-Related Reactions Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors
Erin Hickey Zacholski, PharmD, BCOP, Sarah Rugh, PharmD Candidate, Jenna Marshall, PharmD Candidate, Et al.
November 26, 2024
Pancreatic Cancer The Advanced Practitioners Role in Early Diagnosis and Management
Lindsay Knox, FNP-C
November 26, 2024